Advanced Endo-therapeutic Procedure Registry-based Observational Study

What this Trial Is About

Researchers are evaluating advanced therapeutic endoscopy procedures to provide minimally invasive treatment options for gastrointestinal (GI) diseases such as Zenker Diverticulum, colon polyps, and colorectal cancer. This registry-based observational study at the Centre Hospitalier de l'Université de Montréal aims to improve the quality of advanced endotherapeutic practices by collecting and analyzing data to identify both low-quality and high-quality procedures. The study includes various advanced endoscopic procedures such as Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection (ESD), polypectomy quality assessment for colorectal adenomas/polyps, Radio Frequency Ablation (RFA), Argon Plasma Ablation (APC), and Per Oral Endoscopic Myotomy (POEM). These procedures are recorded prospectively in a protected electronic registry. Each technique involves specific methods, including mucosal resection, submucosal dissection, thermal ablation, and endoscopic myotomy under general anesthesia with expert operators and specialized equipment. Participants undergo these advanced endotherapeutic procedures with data collected on outcomes such as complication rates, completeness of tissue resection, bleeding, perforation, and recurrence over 6 to 18 months. The study monitors technical skills of endoscopists and assesses quality of life after treatment. Safety is tracked through severe complication rates within 14 days post-procedure. This long-term follow-up supports efforts to enhance therapeutic endoscopy quality and patient care.

Advanced Endo-therapeutic Procedure : Registry-based Observational Study